Journal
WATER RESEARCH
Volume 116, Issue -, Pages 65-75Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.watres.2017.03.005
Keywords
Fungal bioreactor; Pharmaceutical active compounds; Continuous treatment; Non-sterile; Hospital wastewater; Pretreatment
Funding
- Spanish Ministry of Economy and Competitiveness [CTM2013-48545-C2]
- European Union through the European Regional Development Fund (ERDF)
- Generalitat de Catalunya [2014-SGR-599, 2014-SGR-476, 2014-SGR-291]
- UAB
- Ramon y Cajal program [RYC-2014-16707]
- Juan de la Cierva Incorporacion research fellowship [JdC-2014-21736]
Ask authors/readers for more resources
Hospital wastewaters are a main source of pharmaceutical active compounds, which are usually highly recalcitrant and can accumulate in surface and groundwater bodies. Fungal treatments can remove these contaminants prior to discharge, but real wastewater poses a problem to fungal survival due to bacterial competition. This study successfully treated real non-spiked, non-sterile wastewater in a continuous fungal fluidized bed bioreactor coupled to a coagulation-flocculation pretreatment for 56 days. A control bioreactor without the fungus was also operated and the results were compared. A denaturing gradient gel electrophoresis (DGGE) and sequencing approach was used to study the microbial community arisen in both reactors and as a result some bacterial degraders are proposed. The fungal operation successfully removed analgesics and anti-inflammatories, and even the most recalcitrant pharmaceutical families such as antibiotics and psychiatric drugs. (C) 2017 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available